Use of pleiotrophin to promote neurogeneration
The invention provides methods for promoting neuron survival in patients by administering pleiotrophin, or nucleic acids encoding pleiotrophin. Uses of the invention include promoting neuron graft survival, preventing or reducing nervous system degeneration, and restoring the nervous system, in patients suffering from, or at risk for, neurodegenerative disorders.
1. A method for promoting dopaminergic neuron graft survival and reinnervation of the tissues of the brain in a patient suffering from Parkinson's disease comprising administering to the striatum or substantia nigra of the patient an amount of pleiotrophin suitable for promoting graft survival and reinnervation, wherein said amount of pleiotrophin promotes reinnervation of the tissues of the brain and survival of dopaminergic neuron grafts administered to the patient.
2. The method of claim 1 , wherein the amount of pleiotrophin is administered to the patient prior to neuron graft transplantation.
3. The method of claim 1 , additionally comprising administering an amount of GDNF to the patient.
4. The method of claim 1 , wherein the Parkinson's disease is early stage Parkinson's disease.
5. The method of claim 1 , wherein the pleiotrophin is administered contemporaneously with graft transplantation.
6. The method of claim 1 , wherein the pleiotrophin is administered following graft transplantation.